Effects of methylglyoxal bis(guanylhydrazone) on tumour and skin responses to hyperthermia in mice.
Effects of methylglyoxal bis(guanylhydrazone) (MGBG) on tumour and skin responses to hyperthermia (42 degrees C) were examined in C3H mice. MGBG (50 mg/kg) was administered intraperitoneally to mice 4 hours before hyperthermic treatment. The tumour (FM3A) growth time was elongated by an amount dependent on the exposure time of treatment at 42 degrees C (60, 90 and 120 min). Pre-treatment of mice with MGBG (50 mg/kg, i.p.) apparently further lengthened the tumour growth time after treatment at 42 degrees C. No significant damage of foot skin was caused by 42 degrees C hyperthermia. Pre-treatment with MGBG did not make the foot skin susceptible to the heating. From these findings, it can be considered that MGBG or related less-toxic compounds may have a clinical advantage for the mild (42 degrees C) hyperthermic treatment in cancer therapy.
D000818:Animals; D003131:Combined Modality Therapy; D005260:Female; D006146:Guanidines / Q000627:therapeutic use*; D006979:Hyperthermia, Induced / Q000009:adverse effects; D008297:Male; D008325:Mammary Neoplasms, Experimental / Q000628:therapy*; D051379:Mice; D008809:Mice, Inbred C3H; D008935:Mitoguazone / Q000627:therapeutic use*; D009368:Neoplasm Transplantation; D012867:Skin / Q000187:drug effects / Q000293:injuries*
D006146:Guanidines; D008935:Mitoguazone